Chung Christine's Form 4 filing
Kyntra Bio, Inc.KYNB · filed Jun 9, 2023
- Accession no.
- 0001209191-23-036064
- Filed
- Jun 9, 2023
- Trade date
- Jun 7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $61.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chung ChristineCIK 0001775295 | Officer (SVP, China Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Common Stock | SSaleDisposed | −1,362 | $17.04 | −$23,208.48 | 251,098 | Direct | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −739 | $17.04 | −$12,592.56 | 250,359 | Direct | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −1,532 | $17.04 | −$26,105.28 | 248,827 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.